Do Clinical Grant Payment Practices in Phase 3 Clinical Trials Influence Subsequent Clinical Investigator Prescribing Behavior?
- Published in:
- Disease Management, 2004, v. 7, n. 1, p. 77, doi. 10.1089/109350704322919014
- By:
- Publication type:
- Article
Works matching IS 1093507X AND DT 2004 AND VI 7 AND IP 1
Results: 7
1
2
Impact of Appropriate Pharmaceutical Therapy for Chronic Conditions on Direct Medical Costs and Workplace Productivity: A Review of the Literature.
- Published in:
- Disease Management, 2004, v. 7, n. 1, p. 61, doi. 10.1089/109350704322919005
- By:
- Publication type:
- Article
3
Diabetes Disease Management in Managed Care Organizations.
- Published in:
- Disease Management, 2004, v. 7, n. 1, p. 47, doi. 10.1089/109350704322918998
- By:
- Publication type:
- Article
4
Savings Opportunities Through Medicaid Disease Management.
- Published in:
- Disease Management, 2004, v. 7, n. 1, p. 35, doi. 10.1089/109350704322918989
- By:
- Publication type:
- Article
5
Racial Comparisons of Health Care and Glycemic Control for African American and White Diabetic Adults in an Urban Managed Care Organization.
- Published in:
- Disease Management, 2004, v. 7, n. 1, p. 25, doi. 10.1089/109350704322918970
- By:
- Publication type:
- Article
6
Estimating the Return on Investment in Disease Management Programs Using a Pre-Post Analysis.
- Published in:
- Disease Management, 2004, v. 7, n. 1, p. 5, doi. 10.1089/109350704322918961
- By:
- Publication type:
- Article
7
5th Annual Disease Management Leadership Forum: DMAA State of the Union Address.
- Published in:
- Disease Management, 2004, v. 7, n. 1, p. 1, doi. 10.1089/109350704322918952
- By:
- Publication type:
- Article